Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors

Clinical trial NCT02478320 · TERMINATED

Trial details

NCT number: NCT02478320
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2016-08-05
Primary completion: 2022-05-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.